Amneal Pharmaceuticals, Inc. AMRX Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s total current liabilities?
- Amneal Pharmaceuticals, Inc. (AMRX) reported total current liabilities of $728.05M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s total current liabilities changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s total current liabilities decreased by 32.3% year-over-year, from $1.08B to $728.05M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s total current liabilities has grown at a 5.4% compound annual growth rate (CAGR), from $676.9M to $881.63M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.